Pfenex Company

Pfenex develops biosimilar therapeutics and novel vaccines for the treatment and prevention of critical human health issues.
Technology: Cancer
Industry: PharmTech
Headquarters: San Diego, California, United States
Founded Date: 2009
Employees Number: 11-50
Funding Status: M&A
Estimated Revenue: $10M to $50M

Visit Website
proteins@pfenex.com
https://www.twitter.com/pfenex
Register and Claim Ownership